Literature DB >> 10982550

Thyroid hormone coordinates respiratory control maturation and adenine nucleotide translocator expression in heart in vivo.

M A Portman1, Y Xiao, K Qian, R L Tucker, S M Parish, X H Ning.   

Abstract

BACKGROUND: The signal transduction mechanism linking mitochondrial ATP synthesis with cytosolic ATP utilization in heart changes during postnatal development in vivo. This maturational process occurs in parallel with accumulation of mitochondrial adenine nucleotide translocator (ANT), which provides a possible site for respiratory control. We postulated that thyroid hormone regulates these maturational processes. METHODS AND
RESULTS: We used (31)P MR spectroscopy to determine the relationship between myocardial high-energy phosphates, phosphocreatine, and ADP and oxygen consumption (MVO(2)) during epinephrine stimulation in 32- to 40-day-old lambs thyroidectomized after birth (THY) and age-matched controls. Steady-state protein and mRNA levels for ANT isoforms and beta-F(1)-ATPase were assessed from left ventricular tissues by Western and Northern blotting. With greater doses of epinephrine, THY attained lower peak MVO(2) than controls (P:<0.05). Controls maintained high-energy phosphate levels, unlike THY, which demonstrated significantly decreased phosphocreatine/ATP and increased cytosolic ADP despite lower peak MVO(2). No significant differences in beta-F(1)-ATPase protein or mRNA occurred between groups. However, ANT isoform mRNA levels were 2-fold greater and protein levels 4-fold greater in control hearts.
CONCLUSIONS: These data imply that the maturational shift away from ADP-mediated respiratory control is regulated by thyroid hormone in vivo. Specific thyroid-modulated increases in ANT mRNA and protein imply that this regulation occurs in part at a pretranslational level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982550     DOI: 10.1161/01.cir.102.11.1323

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Mitochondrial gene expression is regulated at multiple levels and differentially in the heart and liver by thyroid hormones.

Authors:  Erika Fernández-Vizarra; José A Enriquez; Acisclo Pérez-Martos; Julio Montoya; Patricio Fernández-Silva
Journal:  Curr Genet       Date:  2008-05-15       Impact factor: 3.886

Review 2.  PGC-1 coactivators in cardiac development and disease.

Authors:  Glenn C Rowe; Aihua Jiang; Zolt Arany
Journal:  Circ Res       Date:  2010-10-01       Impact factor: 17.367

3.  Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.

Authors:  Outi M Hyyti; Aaron K Olson; Ming Ge; Xue-Han Ning; Norman E Buroker; Youngran Chung; Thomas Jue; Michael A Portman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

4.  Cardiac PPARalpha Protein Expression is Constant as Alternate Nuclear Receptors and PGC-1 Coordinately Increase During the Postnatal Metabolic Transition.

Authors:  Norman E Buroker; Xue-Han Ning; Michael Portman
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

5.  Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.

Authors:  Veronique Deschodt-Arsac; Laurent Arsac; Julie Magat; Jerome Naulin; Bruno Quesson; Pierre Dos Santos
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.